Ose Immunotherapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Ose Immunotherapeutics Depreciation & Amortization Growth & History (OSE)
Ose Immunotherapeutics's depreciation and amortization was €3.2M for fiscal 2025.
View full Ose Immunotherapeutics company overviewOse Immunotherapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.2M | −€62,000 | −1.87% |
| 2024 | 2024-12-31 | €3.3M | €631,000 | +23.55% |
| 2023 | 2023-12-31 | €2.7M | −€116,000 | −4.15% |
| 2022 | 2022-12-31 | €2.8M | €825,000 | +41.88% |
| 2021 | 2021-12-31 | €2.0M | €1.7M | +621.61% |
| 2020 | 2020-12-31 | €273,000 | — | — |
Ose Immunotherapeutics depreciation and amortization trends
Over the last five fiscal years, Ose Immunotherapeutics's depreciation and amortization increased from €273,000 to €3.2M, a change of €3.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ose Immunotherapeutics source filings ↗